- Home Page
-
Solutions
-
CRO Services
- 06 Integrated Solutions
-
11 Featured Solutions
- 01 Innovative Antibody Discovery Platforms With the Super-trillion Ab Libraries
- 02 Screening With the Sub-library of Super-trillion Fully Human Ab Library
- 03 Screening With the Sub-library of Super-trillion Single Domain Ab Library
- 04 Screening With the Sub-library of Super-trillion Common Light Chain Ab Library
- 05 MIT Mouse Recombinant mAb Customization
- 06 MIT Alpaca Recombinant mAb Customization
- 07 Monoclonal and Polyclonal Anti-drug Antibody Customization
- 08 High-quality Gram-level Antibody Production
- 09 Rapid Protein Expression and Purification Service
- 10 Antigen and Antibody Structure Analysis
- 11 Antibody Specificity Analysis
-
11 Staged Solutions
- 01 In-depth Antibody Humanization
- 02 Ultimate Antibody Affinity Maturation
- 03 In Vitro Efficacy Evaluation
- 04 In Vivo Efficacy Evaluation
- 05 Antibody Pharmacokinetic Analysis
- 06 Multidimensional Characterization for Protein
- 07 Antibody Production Cell Line Development
- 08 Research Overexpression Cell Line Construction
- 09 Fermentation Process Development
- 10 Purification Process Development
- 11 Formulation Development
- CPO Projects
-
CRO Services
- Products
- Media
- Activities
- About Us
- Careers
- Supports
Biological Drug R&D, Ask Sanyou Bio
- Home
-
Solutions
SolutionsWe take technology platforms as our leading-edge, continuing to upgrade our integrated services, we strive to build a core service system that can form global core competitiveness.
-
Products
ProductsCommitted to providing high-quality protein, antibody, cell line and detection reagent products.
-
Media
MediaHere, you can get the latest news of Sanyou Biopharmaceuticals.
- Activities
-
About Us
About UsSanyou Bio is a leading international biological high-tech enterprise focusing on R&D and services of innovative biological drugs.
-
Careers
CareersContinuous talent development and growth is regarded as the cornerstone of business and strategy realization.
-
Supports
SupportsGet more instant technical advice and rich material.
Return
Exhibitions
Exhibition Preview | Sanyou Biopharmaceuticals invites you to meet at the Biofuture 2021 Next Generation of Antibody Drug Technology & Cell and Gene Therapy Innovation Conference
Time：2021.05.19
Author：Sanyou Bio
From：Sanyou Bio
Sanyou Biopharmaceuticals invites you to attend the Biofuture 2021 Next Generation of Antibody Drug Technology & Cell and Gene Therapy Innovation Conference, where Dr. Tan Yongcong, Senior Project Director of Sanyou Biopharmaceuticals, will give a keynote speech on "Integrated Solutions for Early Detection of Innovative Antibody Drugs" to exchange and discuss key node technologies related to antibody drug R&D. Meanwhile, Sanyou Biopharmaceuticals will bring the integrated antibody drug R&D solutions to this conference. Sanyou Biopharmaceuticals has always focused on the R&D of innovative antibody drugs. It can provide integrated technology solutions for antibody discovery, in vitro efficacy screening, antibody engineering modification, animal model screening, construction of production cell line and small-scale process development, which can seamlessly link the commercial production and clinical study of antibody drugs.
Tel：400-821-0776
Email：service@sanyoubio.com
Address：3/F, Building 6, No. 188 Xinjunhuan Road, Minhang District, Shanghai
Email：service@sanyoubio.com
Address：3/F, Building 6, No. 188 Xinjunhuan Road, Minhang District, Shanghai